Skin deep. Melanozytenspezifisch regulierte CDK2 als Krebstarget beim Melanom

被引：0
|
作者：
机构：
来源：
Der Hautarzt | 2005年 / 56卷 / 2期
关键词：
D O I：
10.1007/s00105-005-0916-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 191
相关论文
共 3 条
  • [1] CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development
    Macias, Everardo
    de Marval, Paula L. Miliani
    De Siervi, Adriana
    Conti, Claudio J.
    Senderowicz, Adrian M.
    Rodriguez-Puebla, Marcelo L.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (02): : 526 - 535
  • [2] Inverse docking assisted identification of flavonols as c-Kit, CDK2 and mTOR inhibitors for melanoma and non-melanoma skin cancer management
    Roy, T.
    Banang-Mbeumi, S.
    Boateng, S.
    Chamcheu, R. N.
    Walker, A.
    Chamcheu, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S83 - S83
  • [3] Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers
    Roy, Tithi
    Boateng, Samuel T.
    Banang-Mbeumi, Sergette
    Singh, Pankaj K.
    Basnet, Pratik
    Chamcheu, Roxane-Cherille N.
    Ladu, Federico
    Chauvin, Isabel
    Spiegelman, Vladimir S.
    Hill, Ronald A.
    Kousoulas, Konstantin G.
    Nagalo, Bolni Marius
    Walker, Anthony L.
    Fotie, Jean
    Murru, Siva
    Sechi, Mario
    Chamcheu, Jean Christopher
    [J]. BIOORGANIC CHEMISTRY, 2021, 107
1